Skip to content
JoelGalvan

JoelGalvan

View Video Stories
  • Home
  • Business
  • Culture
  • Sports
  • Home
  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.
  • Home
  • rating
  • Page 3

Tag: rating

Goldman Sachs Reiterates a Hold Rating on Viatris (VTRS) With a $10 PT
Posted in Business

Goldman Sachs Reiterates a Hold Rating on Viatris (VTRS) With a $10 PT

Estimated read time 2 min read
Posted on July 14, 2025
by Joelgalvan

Viatris Inc. (NASDAQ:VTRS) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on June 30,…

Learn More Leave a Comment on Goldman Sachs Reiterates a Hold Rating on Viatris (VTRS) With a $10 PT
Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating
Posted in Business

Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating

Estimated read time 2 min read
Posted on July 13, 2025
by Joelgalvan

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is one of the Most Promising AI Stocks to Buy Now. Goldman Sachs began coverage of the company’s…

Learn More Leave a Comment on Goldman Sachs Begins coverage of GLOBALFOUNDRIES (GFS) Stock with a Neutral Rating
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress
Posted in Business

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress

Estimated read time 2 min read
Posted on July 13, 2025
by Joelgalvan

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reiterated…

Learn More Leave a Comment on Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress
Up to 7.5% Yield and a “Strong Buy” Rating? These 3 Dividend Stocks Check Every Box.
Posted in Business

Up to 7.5% Yield and a “Strong Buy” Rating? These 3 Dividend Stocks Check Every Box.

Estimated read time 4 min read
Posted on July 13, 2025
by Joelgalvan

Bullish – green stock market chart with arrow up day trade by Quality Stock Arts via Shutterstock With potentially higher…

Learn More Leave a Comment on Up to 7.5% Yield and a “Strong Buy” Rating? These 3 Dividend Stocks Check Every Box.
Canaccord Genuity Maintained a Buy Rating on Aurora Innovation (AUR)
Posted in Business

Canaccord Genuity Maintained a Buy Rating on Aurora Innovation (AUR)

Estimated read time 2 min read
Posted on July 11, 2025
by Joelgalvan

Aurora Innovation, Inc. (NASDAQ:AUR) is one of the 110 Best Growth Stocks to Buy With Huge Upside Potential. On May 15, George…

Learn More Leave a Comment on Canaccord Genuity Maintained a Buy Rating on Aurora Innovation (AUR)
Reliance Infrastructure achieves three notch credit rating boost post debt reduction
Posted in Business

Reliance Infrastructure achieves three notch credit rating boost post debt reduction

Estimated read time 3 min read
Posted on July 11, 2025
by Joelgalvan

Reliance Infrastructure, led by Anil Ambani, has experienced a significant uplift in its credit rating, reflecting a fundamental shift in…

Learn More Leave a Comment on Reliance Infrastructure achieves three notch credit rating boost post debt reduction
Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT
Posted in Business

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT

Estimated read time 2 min read
Posted on July 11, 2025
by Joelgalvan

MannKind Corporation (NASDAQ:MNKD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 8, Wells Fargo analyst Tiago…

Learn More Leave a Comment on Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT
Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating
Posted in Business

Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating

Estimated read time 2 min read
Posted on July 11, 2025
by Joelgalvan

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley…

Learn More Leave a Comment on Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating
REC, PFC shares rally up to 3% after Morgan Stanley initiates coverage with overweight rating
Posted in Business

REC, PFC shares rally up to 3% after Morgan Stanley initiates coverage with overweight rating

Estimated read time 3 min read
Posted on July 10, 2025
by Joelgalvan

Shares of power financing PSUs REC Ltd and Power Finance Corporation (PFC) climbed up to 3% on Thursday after Morgan…

Learn More Leave a Comment on REC, PFC shares rally up to 3% after Morgan Stanley initiates coverage with overweight rating
Performant Healthcare Draws Buy Rating Despite Insider Sell-Off
Posted in Business

Performant Healthcare Draws Buy Rating Despite Insider Sell-Off

Estimated read time 2 min read
Posted on July 9, 2025
by Joelgalvan

Performant Healthcare, Inc. (NASDAQ:PHLT) is one of the 10 best high risk penny stocks to invest in. Craig-Hallum maintains a…

Learn More Leave a Comment on Performant Healthcare Draws Buy Rating Despite Insider Sell-Off

Posts navigation

← Older Articles
Newer Articles →

Recent Posts

  • The key flaws that could bring high-flying Crows unstuck in September
  • Tougen Anki Season 2: Rumours & Release Date
  • Latest Odds Reveal Betting Favorites To Land Ben Simmons
  • 5 common mistakes people make when ‘cash stuffing’
  • Men’s draw set for National Bank Open in Toronto

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Business
  • Culture
  • Sports
© https://joelgalvan.site/-All rights reserved. Theme Blognest designed by WPInterface.